FindTrial
Sign In

Effect and mechanism of probiotics-based adjuvant therapy in hemorrhoid conservative treatment and endoscopic injection sclerotherapy

Effect and mechanism of probiotics-based adjuvant therapy in hemorrhoid conservative treatment and endoscopic injection sclerotherapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046496
Enrollment
Unknown
Registered
2021-05-16
Start date
2021-06-01
Completion date
Unknown
Last updated
2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemorrhoid

Interventions

Group A1:Conservative treatment with probiotics
Group A2:Placebo treatment
GroupB1:Probiotics combined with surgical treatment
Group B2:Placebo combined with surgery
Healthy control group:Nil

Sponsors

The First hospital of Nanchang
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 75 years; 2. Hemorrhoids: (1) Grade I-II receiving conservative treatment; (2) Grade I-III patients receiving endoscopic injection sclerotherapy; 3. Informed consent.

Exclusion criteria

Exclusion criteria: 1. With anal fistula,perianal abscess,anal papilloma or rectal tumor; 2. Abnormal blood and urine routine, Pt, APTT, AST, alt, AKP, TBIL, bun, SCR, ECG; 3. Hemoglobin < 60g/L or abnormal coagulation function; 4. Allergic constitution; 5. Female in breast nursing or gestation, or to be pregnant; 6. People who have done surgery; 7. People who have participated in other clinical trials; 8. People who are excluded by researchers.

Design outcomes

Primary

MeasureTime frame
Symptoms of hemorrhoids;Intestinal microecology;—

Countries

China

Contacts

Public ContactFang Nian

The First Hospital of Nanchang

fnian3893@126.com+86 13970053893

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026